1 Immune response-modulating drugs such as thalidomide may be of therapeutic value in the treatment of chronic in¯ammatory bowel diseases including Crohn's disease (CD). In the present study, we have investigated whether thalidomide exerts this e ect by impairing endothelial cellleukocyte interaction through down-regulation of the expression of pro-in¯ammatory gene products in these cells. 2 Transient CD-like colitis was induced in male Wistar rats by single enema with trinitrobenzene sulphonic acid (TNBS) in ethanol followed by macroscopic scoring, histology, intravital microscopy, RT ± PCR and immunohistochemistry (IHC) analyses. Thalidomide or its analogue supidimide were administered in olive oil by intragastric instillation 6 h prior to the induction of colitis and then daily for one week. 3 Both thalidomide and supidimide (200 mg kg 71 d 71 ) signi®cantly attenuated TNBS-induced colitis as compared to vehicle-treated control animals (44 and 37% inhibition, respectively), and this e ect persisted for 7 days post cessation of thalidomide treatment (46% inhibition). 4 Moreover, thalidomide signi®cantly reduced leukocyte sticking to postcapillary venular endothelial cells in the submucosa (by 45%), improved functional capillary density and perfusion, and attenuated endothelial interleukin-8 expression, as judged by IHC analysis. According to RT ± PCR analysis, both thalidomide and supidimide also signi®cantly reduced vascular cell adhesion molecule-1 mRNA expression in the a ected part of the descending colon. 5 These ®ndings suggest that thalidomide and one of its derivatives impairs CD-like TNBS-induced colitis in the rat by down-regulating endothelial adhesion molecule and chemokine expression and, as a consequence, the interaction of these cells with circulating leukocytes.

The bromine additions to methylenecyclopropane (1), bicyclopropylidene (2), and spirocyclopropanated methylenecyclopropanes and bicyclopropylidenes 3-6 in methanol at 25 degrees C proceed essentially with the same rate as those to the corresponding oligomethyl-substituted ethylenes. An increasing number of spiroannelated three-membered rings enhances the rate of bromination and stabilizes the intermediate cyclopropyl bromonium cations against ring opening in the course of bromine addition. Calculations at the B3LYP/6-311G(d,p) level show that unsymmetrical bromonium ions are the intermediates, and that they are stabilized by the spiroannelation with cyclopropane rings. The bromonium ion derived from 1 is less stable by 6.3 kcal mol-1 than that from isobutene. One or two spirocyclopropane rings as in 3 and 4 stabilize the corresponding bromonium ion by 9.6 and 16.4 kcal mol-1, respectively, while one or two alpha-cyclopropyl substituents as in ethenylcyclopropane (7) and 1,1-dicyclopropylethene (8) stabilize the corresponding bromonium ions by 13 and 29 kcal mol-1, respectively. The experimental bromination rates of all the studied alkenes correlate reasonably well (r2 = 0.93) with calculated relative energies of the corresponding bromonium ions. The correlation is even better within the series of methylenecyclopropanes 1, 3, and 4 (r2 = 0.974) and bicyclopropylidenes 2, 5, and 6 (r2 = 0.999). The experimental bromination rates also correlate fairly well with the first ionization energies of the corresponding alkenes 1-12 (with r2 = 0.963) and 13-19 (with r2 = 0.991). The calculated preferred nucleophilic attack of a water molecule at both the C1' and C1 atoms of representative bromonium ions conforms well to the experimentally observed product distribution.